Skip to content
healthcare.dev

Adrenal Liquescence

NDC 83027-0014, Glycyrrhiza Glabra, Rosa Canina, Aralia Quinquefolia (American Ginseng), Glandula Suprarenalis (Bovine), Adrenalinum, Ephedra Vulgaris, Natrum Muriaticum, Zincum Metallicum, Adrenocorticotrophin, liquid, from Nutritional Specialties, Inc..

Product NDC
83027-0014
Status
Listed
Labeler
Nutritional Specialties, Inc.
Dosage form
LIQUID
Route
ORAL
Product type
HUMAN OTC DRUG
Marketing category
UNAPPROVED HOMEOPATHIC
Application
—
DEA schedule
None
Request
curl https://api.healthcare.dev/v1/drugs/ndc/83027-0014 \
  -H "Authorization: Bearer $HDEV_API_KEY"

Product

Active ingredients and packages

Active ingredients

  • GLYCYRRHIZA GLABRA2 [hp_X]/mL
  • ROSA CANINA FRUIT3 [hp_X]/mL
  • AMERICAN GINSENG3 [hp_X]/mL
  • BOS TAURUS ADRENAL GLAND6 [hp_X]/mL
  • EPINEPHRINE12 [hp_X]/mL
  • EPHEDRA DISTACHYA FLOWERING TWIG12 [hp_X]/mL
  • SODIUM CHLORIDE12 [hp_X]/mL
  • ZINC12 [hp_X]/mL
  • CORTICOTROPIN15 [hp_C]/mL

Pharmacologic classes

Adrenergic alpha-Agonists [MoA]; Adrenergic beta-Agonists [MoA]; Adrenocorticotropic Hormone [CS]; Adrenocorticotropic Hormone [EPC]; Allergens [CS]; Catecholamine [EPC]; Catecholamines [CS]; Cell-mediated Immunity [PE]; Dietary Proteins [CS]; Increased Histamine Release [PE]; Non-Standardized Food Allergenic Extract [EPC]; Non-Standardized Plant Allergenic Extract [EPC]; Plant Proteins [CS]; alpha-Adrenergic Agonist [EPC]; beta-Adrenergic Agonist [EPC]

Package NDCNDC-11Package
83027-0014-183027001401120 mL in 1 BOTTLE, GLASS (83027-0014-1)

Linked data

RxNorm, label and prices

RxNorm concepts

RxNorm links no concept to this product's packages.

Related lookups

No FDA label, Medicare Part B payment limit or NADAC price is linked to this product.

Use it

Look up 83027-0014 from code or an agent

curl
curl https://api.healthcare.dev/v1/drugs/ndc/83027-0014 \
  -H "Authorization: Bearer $HDEV_API_KEY"
MCP prompt
Using the healthcare.dev MCP server, look up NDC 83027-0014. Tell me the product, its labeler, dosage form and route, its packages, and the RxNorm concepts it maps to.

Source: FDA, release 2026-10-23. Public domain. Reference data, not medical advice.